IBIO vs SNPS · rev $100.0K vs P/E 63, rev $7.16B
iBio, Inc. Common Stock (IBIO) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
IBIO currently screens at market cap $13.4M. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the IBIO and SNPS stock pages for the full models.
Not investment advice.